The progressive state lawmaker surged from relative obscurity to become the main foil to former Gov. Andrew Cuomo’s comeback bid in the Democratic primary.
Related Posts
JPMorgan’s top biopharma picks for 2025
The Nasdaq Biotechnology Index (NBI) has gained 6.5% this year, outpacing gains from both the S&P 500 and tech-heavy Nasdaq Composite.
Novo Nordisk’s next-gen obesity drug CagriSema had investors excited. Now they’re not so sure
Novo Nordisk’s hopes of heralding a new era of obesity treatment with its next-generation CagriSema drug may be in doubt after a series of trial […]